While there are reports in which anti-Tim-3 antibody treatment did not lead to any inhibition of tumor growth38, there are other studies in which anti-Tim-3 antibody did lead to a slowing of tumor progression by promoting type I anti-tumor immunity39. Here, HAVCR2 is linked to neoplasm.